Cardiac Surgery

Cardiothoracic surgery includes coronary artery bypass surgery (CABG), heart valve repair or replacement, left ventricular assist device (LVAD) placement, heart transplant, assisting in minimally invasive transcatheter valve structural heart procedures such as TAVR, left atrial appendage (LAA) occlusion, septal myectomy, surgical ablation for arrhythmias, and reconstruction of the heart in congenial heart disease cases. 

artificial intelligence AI in healthcare

Women less likely to receive DCD heart transplants

Donation after circulatory death heart transplants are gaining popularity in the United States, but men are much more likely to be selected for one. 

man making a decision

At a crossroads: Surgical heart valve innovation slows as transcatheter treatments keep evolving

Has the success of TAVR and other interventional techniques had a negative impact on surgical valve innovation? Two surgeons shared their concerns in a new commentary. 

Tria Mitral Valve Foldax

Polymer heart valve, the first of its kind to gain commercial approval, linked to positive 1-year data

The new-look mitral valve is built using LifePolymer, a proprietary material that does not include any animal tissue. Both the frame and its leaflets are robotically generated to match each patient’s anatomy.

Thumbnail

Female heart surgeons take home much lower salaries

Both base salaries and total compensation are consistently lower for women than men, according to new survey data. The disparities in cardiac surgery are often worse than those found in other healthcare specialties.

physician acceptance of generative AI

Society of Thoracic Surgeons provides on-the-go risk evaluations with new mobile app

The STS Risk Calculator App, available on both iOS and Android devices, gives users improved access to real-time risk assessments.

heart surgery Baylor St. Luke's Medical Center

Surgeons complete first fully robotic heart transplant in US history

The historic procedure was performed in Texas on a 45-year-old patient who had been hospitalized for months with advanced heart failure.

Ancora Heart AccuCinch Ventricular Restoration System heart failure FDA

First 250 patients enrolled in transcatheter heart failure device trial to reduce LV size

The first 250 patients has been enrolled in the CORCINCH-HF U.S. pivotal trial evaluating the AccuCinch Transcatheter Left Ventricular Restoration System in patients with HFrEF.

the words "FDA recall" on a board

FDA declares Class I recall on heart surgery procedure kits from Medline

The news is related to an earlier recall of more than 316,000 Medtronic devices.